SpringWorks Therapeutics ...

NASDAQ: SWTX · Real-Time Price · USD
46.99
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM

SpringWorks Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-253.93M -258.13M -275.16M -301.06M -339.07M -325.1M -304.96M -297.91M -289.04M -277.42M -259.31M -227.96M -205.92M -173.91M -106.57M -87.18M -60.07M
Depreciation & Amortization
3.84M 3.47M 2.99M 2.6M 2.14M 1.67M 1.38M 1.1M 910K 765K 656K 563K 488K 490K 454K 430K 389K
Stock-Based Compensation
108.63M 109.14M 107.74M 104.87M 101.6M 94.53M 88.39M 83.81M 79.27M 72.97M 65.92M 58.12M 48.48M 38.44M 29.6M 21.93M 15.74M
Other Working Capital
62.06M 49.99M 31.02M -31.97M 9.44M 22.26M 8.41M 36.95M 37.62M 33.94M 33.36M 7.65M -5K 3.04M 5.95M 5.27M 4.36M
Other Non-Cash Items
-50.16M -4.72M -5.89M 48.58M 46.81M 2.93M 3.42M 4.75M 4.98M 4.02M 3.3M 1.77M 1.34M 993K 1.94M 1.87M 1.81M
Deferred Income Tax
n/a n/a 1.83M 2.86M 3.76M 3.76M 1.93M 901K n/a n/a 301K 568K 727K 988K 687K 420K 261K
Change in Working Capital
42.82M 18.66M 3.7M -47.72M -11.13M -583K -4.45M 23.91M 29.19M 38.1M 35.45M 5.94M -580K 5.12M 7.39M 8.26M 4.97M
Operating Cash Flow
-165.43M -175.6M -208.8M -233.89M -239.91M -222.79M -214.29M -183.43M -174.69M -161.56M -153.68M -161M -155.46M -127.88M -66.5M -54.27M -36.9M
Capital Expenditures
-8.9M -9.45M -1.1M -14.12M -4.99M -7.38M -11.44M -11.35M -10.79M -10.2M -9.94M -6.75M -4.36M -2.02M -566K -398K -527K
Cash Acquisitions
8.23M n/a -2.3M -6.92M -3.83M 1.61M 14.11M 10.48M 3.2M 6M -2.7M -2.36M 1.97M 2.02M 566K 231K 99K
Purchase of Investments
-203.22M -285.1M -470.7M -530.58M -589.45M -575.72M -722.37M -625.71M -525.96M -481.05M -154.51M -232.48M -242.29M -305.42M -469.59M -519.02M -529.06M
Sales Maturities Of Investments
348.09M 378.58M 382.48M 441.85M 552.05M 620.66M 575.57M 530.44M 400.32M 279.85M 364.25M 388.58M 387.58M 391.03M 274.79M 160.7M 83.5M
Other Investing Acitivies
-27.72M -35.95M -33.65M -9.55M -12.64M 97.17M 84.67M 178.06M 210.43M 137.66M 146.35M 56.25M 26.84M -2.02M -566K -127.63M -195.56M
Investing Cash Flow
116.47M 64.55M -108.81M -102.85M -42.39M 34.75M -161.05M -109.42M -143.42M -215.6M 195.59M 145.15M 140.93M 83.59M -195.37M -358.72M -449.59M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-1.94M -8.44M -8.17M -7.93M -7.37M -2.8M -1.21M -1.15M -1.02M n/a -1.34M -1.13M -906K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-3.35M 13.2M 12.05M 10.28M 6M 139K 413K 768K 893K 1.98M 1.92M 1.97M 1.97M 1.16M 1.29M 1.3M 1.25M
Financial Cash Flow
-5.29M 4.76M 303.18M 301.65M 297.94M 296.64M -2.13M 338.34M 338.59M 340.7M 340.65M 842K 1.06M 1.16M 270.89M 270.89M 270.84M
Net Cash Flow
-53.63M -105.67M -13.81M -35.09M 15.64M 108.6M -377.48M 45.49M 20.48M -36.46M 382.56M -15.02M -13.47M -43.13M 9.02M -142.09M -215.65M
Free Cash Flow
-174.33M -185.05M -209.9M -248.01M -244.89M -230.18M -225.73M -194.78M -185.48M -171.76M -163.62M -167.75M -159.82M -129.89M -67.06M -54.66M -37.42M